Abstract
The group of congenital disorders of glycosylation (CDG) has expanded tremendously since its first description in 1980, with around 70 distinct disorders described to date. A great phenotypic variability exists, ranging from multisystem disease to single organ involvement. Skin manifestations, although inconsistently present, are part of this broad clinical spectrum. Indeed, the presence of inverted nipples, fat pads and orange peel skin in a patient with developmental delay are considered as a hallmark of CDG, particularly seen in PMM2 deficiency. However, over the years many more dermatological findings have been observed (e.g., ichthyosis, cutis laxa, tumoral calcinosis…). In this review we will discuss the variety of skin manifestations reported in CDG. Moreover, we will explore the possible mechanisms that link a certain glycosylation deficiency to its skin phenotype.
Similar content being viewed by others
References
Avram MM (2004) Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther 6(4):181–185
Berk DR, Bentley DD, Bayliss SJ, Lind A, Urban Z (2012) Cutis laxa: a review. J Am Acad Dermatol 66(5):842.e1–17
Bouvet C, Moreau S, Blanchette J, de Blois D, Moreau P (2008) Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis. Arterioscler Thromb Vasc Biol 28(5):856–862
Cartwright BR, Goodman JM (2012) Seipin: from human disease to molecular mechanism. J Lipid Res 53(6):1042–1055
Chefetz I, Sprecher E (2009) Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. Biochim Biophys Acta 1792(9):847–852
Chefetz I, Kohno K, Izumi H, Uitto J, Richard G, Sprecher E (2009) GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim Biophys Acta 1792(1):61–67
Chia KY, Tey HL (2013) Approach to hypohidrosis. J Eur Acad Dermatol Venereol 27(7):799–804
Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD (2009) A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol 18(9):741–749
Diao JS, Zhang X, Xia WS et al (2009) Aberrant Notch signaling: a potential pathomechanism of vitiligo. Med Hypotheses 73(1):70–72
Dou GR, Wang YC, Hu XB et al (2008) RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB J 22(5):1606–1617
Elias PM, Williams ML, Feingold KR (2012) Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders. Clin Dermatol 30(3):311–322
Fischer B, Dimopoulou A, Egerer J et al (2012) Further characterization of ATP6V0A2-related autosomal recessive cutis laxa. Hum Genet 131(11):1761–1773
Groux-Degroote S, van Dijk SM, Wolthoorn J et al (2008) Glycolipid-dependent sorting of melanosomal from lysosomal membrane proteins by lumenal determinants. Traffic 9(6):951–963
Gründahl JEH, Guan Z, Rust S et al (2012) Life with too much polyprenol: polyprenol reductase deficiency. Mol Genet Metab 105(4):642–651
Hassed SJ, Wiley GB, Wang S et al (2012) RBPJ mutations identified in two families affected by Adams-Oliver syndrome. Am J Hum Genet 91(2):391–395
Hennet T (2012) Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim Biophys Acta 1820(9):1306–1317
Hirata T, Fujita M, Kanzawa N, Murakami Y, Maeda Y, Kinoshita T (2013) Glycosylphosphatidylinositol mannosyltransferase II is the rate-limiting enzyme in glycosylphosphatidylinositol biosynthesis under limited dolichol-phosphate mannose availability. J Biochem 154(3):257–264. doi:10.1093/jb/mvt045
Hucthagowder V, Morava E, Kornak U et al (2009) Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival. Hum Mol Genet 18(12):2149–2165
Jaeken J, Matthijs G, Barone R, Carchon H (1997) Carbohydrate deficient glycoprotein (CDG) syndrome. J Med Genet 34:73–76
Jonas E, Schreinemachers HJ, Kleinwächter T et al (2008) QTL for the heritable inverted teat defect in pigs. Mamm Genome 19(2):127–138
Kahrizi K, Hu CH, Garshasbi M et al (2011) Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3. Eur J Hum Genet 19(1):115–117
Kern A, Bryant-Greenwood GD (2009) Mechanisms of relaxin receptor (LGR7/RXFP1) expression and function. Ann N Y Acad Sci 1160:60–66
Krajnc-Franken MAM, Van Disseldorp AJM, Koenders JE, Mosselman S, Van Duin M, Gossen JA (2004) Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 24(2):687–696
Lecca MR, Maag C, Berger EG, Hennet T (2011) Fibrotic response in fibroblasts from congenital disorders of glycosylation. J Cell Mol Med 15(8):1788–1796
Lefeber DJ, de Brouwer APM, Morava E et al (2011) Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan O-mannosylation. PLoS Genet 7(12):e1002427
Leyvraz C, Charles RP, Rubera I et al (2005) The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 170(3):487–496
Li M, Cheng R, Liang J et al (2013) Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized dowling-degos disease. Am J Hum Genet 92(6):895–903
Morava E, Zeevaert R, Korsch E et al (2007) A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. Eur J Hum Genet 15(6):638–645
Moriyama M, Osawa M, Mak SS et al (2006) Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol 173(3):333–339
Ng BG, Hackmann K, Jones M et al (2012) Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet 90(4):685–688
Ogawa R, Hsu CK (2013) Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degeneration. J Cell Mol Med 17(7):817–822. doi:10.1111/jcmm.12060
Okuyama R, Tagami H, Aiba S (2008) Notch signaling: its role in epidermal homeostasis and in the pathogenesis of skin diseases. J Dermatol Sci 49(3):187–194
Paller AS, van Steensel M, Rodriguez-Martín M et al (2011) Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism. J Invest Dermatol 131(11):2242–2248
Pinnix CC, Herlyn M (2007) The many faces of Notch signaling in skin-derived cells. Pigment Cell Res 20(6):458–465
Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E (2011) Calcinosis cutis: part II Treatment options. J Am Acad Dermatol 65(1):15–22
Reynders E, Foulquier F, Annaert W, Matthijs G (2011) How Golgi glycosylation meets and needs trafficking: the case of the COG complex. Glycobiology 21(7):853–863
Romero-Fernandez W, Borroto-Escuela DO, Alea MP, Garcia-Mesa Y, Garriga P (2011) Altered trafficking and unfolded protein response induction as a result of M3 muscarinic receptor impaired N-glycosylation. Glycobiology 21(12):1663–1672
Rymen D, Keldermans L, Race V et al (2012) COG5-CDG: expanding the clinical spectrum. Orphanet J Rare Dis 10(7):94
Rymen D, Peanne R, Millón MB et al (2013) MAN1B1 deficiency: an unexpected CDG-II. PLOS Genet 9(12):e1003989
Sakaidani Y, Nomura T, Matsuura A et al (2011) O-linked-N-acetylglucosamine on extracellular protein domains mediates epithelial cell-matrix interactions. Nat Commun 13(2):583
Schenk B, Imbach T, Frank CG et al (2001) MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 108(11):1687–1695
Shafir R, Bonne-Tamir B, Ashbel S, Tsur H, Goodman RM (1979) Genetic studies in a family with inverted nipples (mammillae invertita). Clin Genet 15(4):346–350
Shaheen R, Faqeih E, Sunker A et al (2011) Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome. Am J Hum Genet 89(2):328–333
Shaheen R, Aglan M, Keppler-Noreuil K et al (2013a) Mutations in EOGT confirm the genetic heterogeneity of autosomal-recessive Adams-Oliver syndrome. Am J Hum Genet 92(4):598–604
Shaheen R, Ansari S, Alshammari MJ et al (2013b) A novel syndrome of hypohidrosis and intellectual disability is linked to COG6 deficiency. J Med Genet 50(7):431–436
Simpson MA, Cross H, Proukakis C et al (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11):1225–1229
Southgate L, Machado RD, Snape KM et al (2011) Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies. Am J Hum Genet 88(5):574–585
Sprong H, Degroote S, Claessens T et al (2001) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. J Cell Biol 155(3):369–380
Stahl M, Uemura K, Ge C, Shi S, Tashima Y, Stanley P (2008) Roles of Pofut1 and O-fucose in mammalian Notch signaling. J Biol Chem 283(20):13638–13651
Suzuki D, Yamada A, Amano T et al (2009) Essential mesenchymal role of small GTPase Rac1 in interdigital programmed cell death during limb development. Dev Biol 335(2):396–406
Tarutani M, Itami S, Okabe M et al (1997) Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A 94(14):7400–7405
Terranova F, Berardesca E, Maibach H (2006) Cellulite: nature and aetiopathogenesis. Int J Cosmet Sci 28(3):157–167
Ungar D, Oka T, Brittle EE et al (2002) Characterization of a mammalian Golgi-localized protein complex, COG, that is required for normal Golgi morphology and function. J Cell Biol 157(3):405–415
Vauclair S, Nicolas M, Barrandon Y, Radtke F (2005) Notch1 is essential for postnatal hair follicle development and homeostasis. Dev Biol 284(1):184–193
Wang H, Bright A, Xin B, Bockoven JR, Paller AS (2013) Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency. Am J Med Genet A 161(4):875–879
Wu X, Steet R, Bohorov O et al (2004) Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med 10(5):518–523
Wu X, Quondamatteo F, Lefever T et al (2006) Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. Genes Dev 20(5):571–585
Yan Y, Scott DJ, Wilkinson TN, Ji J, Tregear GW, Bathgate RA (2008) Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Biochemistry 47(26):6953–6968
Zeevaert R, de Zegher F, Sturiale L et al (2013) Bone dysplasia as a key feature in three patients with a novel Congenital Disorder of Glycosylation (CDG) Type II due to a deep intronic splice mutation in TMEM165. JIMD Rep 8:145–152
Acknowledgements
This work was funded by grants from the Research Foundation (FWO) Flanders (G.0553.08 and G.0505.12) and by grant ERARE11-135 of the ERA-Net for Research Programs on Rare Diseases Joint Transnational Call 2011 (EURO-CDG). Daisy Rymen is research assistant of the FWO.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Eva Morava
Rights and permissions
About this article
Cite this article
Rymen, D., Jaeken, J. Skin manifestations in CDG. J Inherit Metab Dis 37, 699–708 (2014). https://doi.org/10.1007/s10545-014-9678-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-014-9678-7